Parexel International Corporation

Parexel International Corporation is a leading global contract research organization (CRO) providing a comprehensive suite of biopharmaceutical services to help clients transform scientific discoveries into new treatments. Founded in 1982 and headquartered in Durham, North Carolina, the company specializes in clinical development capabilities, regulatory consulting, and market access services across all phases of clinical trials. With a workforce of over 21,000 professionals operating in approximately 100 countries, Parexel leverages its deep therapeutic and technical expertise to streamline drug development and improve patient access to life-changing therapies. The organization is recognized for its patient-first culture and its commitment to driving innovation within the pharmaceutical, biotechnology, and medical device industries worldwide.